Development of synthetic lethality in cancer: molecular and cellular classification

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Genetically targeted cancer therapies are gaining significant interest.
• Synthetic lethality presents a novel approach for treating cancers with previously untargetable mutations.
• Despite promise, clinical application faces challenges due to a lack of systematic understanding.

Purpose of the Study:

• To propose a novel, systematic classification of synthetic lethality based on biological mechanism specificity.
• To review and categorize preclinical findings within this new classification framework.
• To discuss clinical applications and future directions of synthetic lethality.

Main Methods:

• Development of a novel classification system for synthetic lethality.
• Categorization based on specificity: gene level, pathway level, organelle level, and conditional synthetic lethality.
• Review and classification of recent preclinical synthetic lethality findings.

Main Results:

• A systematic classification of synthetic lethality is proposed, encompassing gene, pathway, organelle, and conditional levels.
• Preclinical findings are reviewed and categorized according to the proposed classification.
• Current synthetic lethality drugs and their clinical applications are discussed.

Conclusions:

• The proposed classification provides a framework for understanding synthetic lethality mechanisms and applications.
• Addressing current challenges through systematic assessment is crucial for advancing synthetic lethality in clinical practice.
• This classification offers insights into future directions for synthetic lethality-driven cancer therapies.